Stockreport

Eleven Biotherapeutics to Present at 2018 BIO CEO & Investor Conference

ELEVEN BIOTHERAPEUTICS  (EBIO) 
Last eleven biotherapeutics earnings: 5/15 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.elevenbio.com/investor-relations
PDF CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidat [Read more]